← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Akanocure Pharmaceuticals, Inc.
West Lafayette, IN
$2,430,995
Total funding
4
Grants
Funding over time
peak $1M · FY2018–24$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NSF$2,430,995 · 4
By mechanism
—$2,430,995 · 4
Investigators at Akanocure Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
SBIR Phase II: A Novel Host-Directed Broad-Spectrum Antiviral and Efficient Immunomodulatory Agent Against Coronaviruses: Lead Optimization Studies$1,000,000
· FY2024 · TIP
SBIR Phase II: Multiplex Expansion of the Chiral Carbon Catalog Platform towards Stereo-enriched Non-propionate Chemical Classes and Industrial Applications$949,999
· FY2020 · TIP
SBIR Phase I: AK-423: A broad-spectrum antiviral and immunomodulatory agent (COVID-19)$256,000
· FY2021 · TIP
SBIR Phase I: Novel Stereo-enriched Libraries as Commercial Complex Building Blocks for Facile Development of Biologically Active Compounds on Large Scale$224,996
· FY2018 · TIP